NovoCure
NVCR
NVCR
227 hedge funds and large institutions have $1.7B invested in NovoCure in 2025 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 71 increasing their positions, 76 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 47
38% less capital invested
Capital invested by funds: $2.73B → $1.7B (-$1.03B)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
227
Holding in Top 10
2
Calls
$21.2M
Puts
$2.68M
Top Buyers
| 1 | +$49.6M | |
| 2 | +$27.4M | |
| 3 | +$19.3M | |
| 4 |
QCM
Quantinno Capital Management
New York
|
+$12.4M |
| 5 |
DM
Deerfield Management
New York
|
+$11.6M |
Top Sellers
| 1 | -$50.4M | |
| 2 | -$21.4M | |
| 3 | -$12.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.7M |
| 5 |
SCM
Superstring Capital Management
New York
|
-$8.55M |
